搜尋結果
MIMS Psychiatry Singapore brings you the latest medical news on mental health, with info on clinical trials, research, conferences on schizophrenia, insomnia, depression, OCD, dementia, bipolar disorder, PTSD, anxiety disorders etc During the launch of Nicorette ® QuickMist at the Kuala Lumpur Nicotine Addiction International Conference (KLNAC) 2023, a panel of distinguished experts led the ...
2024年4月30日 · Treatment with lecanemab continue to provide benefits to patients with early Alzheimer’s disease (AD) through 24 months, according to the results of the ongoing open-label extension study of Clarity AD. Those who have been treated much later also show disease
- Stephen Padilla
